Princeton, NJ, January 14 – BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic partnership with Orchestra Life Sciences (OLS), a premier technical consultancy firm specializing in advanced therapy …

· Princeton Facility Designated as New Headquarters· Regional Multi-Site Operations to Advance Clinical-to-Commercial Capabilities· $12M Capital Investment for State-of-the-Art Operations and Digital Advancements Newark, NJ, December 17, 2024 – BioCentriq, a leading cell therapy contract …

Newark, NJ, September 19, 2024 – BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announces that it has appointed Syed T. Husain as its new Chief Executive Officer (CEO), and as …

Watch Chathuranga De Silva, Ph.D., Executive Director, Business Development at BioCentriq in an engaging interview with Alicia Didsbury during the ISCT 2024 Annual Meeting in Vancouver. In this interview, Chat highlights BioCentriq’s unwavering commitment to …

In June, BioCentriq hosted a webinar called End-to-End Automated Manufacturing of Low-Seed CAR-T Cells where we explored the intricate pathway to achieving commercial readiness in CAR-T cell therapy. In this session, we address crucial aspects …

Explore BioCentriq’s capabilities and expertise presented by Chathuranga De Silva, Ph.D., Executive Director of Business Development at BioCentriq. In this session, recorded during Outsourced Pharma’s Cell & Gene Capacity Update July 2024, Chat delivers an …

Welcome to Biotech Banter, where we bring you exclusive insights from top experts in the biotech industry. Our thought leaders and seasoned professionals explore the challenges and opportunities of advancing cell and gene therapies to …

Data will detail how the Terumo BCT’s Quantum Flex® Cell Expansion System and Finia® Fill and Finish System with BioCentriq’s LEAP™ Advanced Therapy Platform can help accelerate delivery of CAR-T therapies to patients LAKEWOOD, Colo., …

This month, BioCentriq hosted a webinar called The Role of Platform Processes in Cell Therapy. It explored the challenges associated with cell therapy manufacturing, including high cost and complexity, and offered an alternate pathway for …

Upcoming Webinar: The Role of Platform Processes in Cell Therapy Manufacturing and Development  Date & Time: September 13, 2023 | 02:00 PM EDT | Register Now!  Cell therapies can revolutionize treatment possibilities, offering potential cures …

Discover how you can reduce timelines and costs, de-risk clinical trials and get to patients faster with BioCentriq’s LEAPTM platform for advanced therapies. Discover BioCentriq’s Capabilities  Our team is ready to meet with you and …

BioCentriq is happy to announce that we’ve been selected to present our capabilities at this year’s Meeting on the Mesa. The conference is from October 10-12 and is in Carlsbad, California. Organized by the Alliance …